At a glance
- Originator Pharmacia Corporation
- Class Anti-inflammatories; Antiasthmatics; Neuroprotectants
- Mechanism of Action Antioxidants; Lipid peroxidation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Stroke
Most Recent Events
- 03 Jan 2001 No-Development-Reported for Asthma in USA (Unknown route)
- 03 Jan 2001 No-Development-Reported for Stroke in USA (Unknown route)
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation